C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms

Patents for C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
11/2003
11/20/2003	CA2485167A1 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
11/06/2003	US20030207823 Novel diabetes imaging probes
10/2003
10/23/2003	WO2003086563A2 Diabetes imaging probes
10/23/2003	WO2003043960A3 IMPROVED PURIFICATION OF 4, 4'(5')-DI-t-BUTYLCYCLOHEXANO-18-CROWN-6
10/23/2003	US20030199688 Macrocyclic module compositions
10/22/2003	CN1125071C Phthalocyanine and use of phthalocyanine as marking agent
09/2003
09/16/2003	US6620325 Purification process for cyclosporin
08/2003
08/27/2003	EP1337278A2 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
08/14/2003	WO2003067286A2 Nanofilm and membrane compositions
08/14/2003	WO2003066646A2 Macrocyclic module compositions
08/14/2003	CA2475646A1 Macrocyclic module compositions
08/14/2003	CA2475567A1 Nanofilm and membrane compositions
07/2003
07/23/2003	EP0983274B1 Phthalocyanine and use of phthalocyanine as a marking agent
06/2003
06/05/2003	US20030105375 An ion-containing compound is admixed with macromolecular crown ether or derivatives to form an extractant/ion complex, and the predetermined extractant/ion complex is separated from the diluent by using the new phase affinity
05/2003
05/30/2003	WO2003043960A2 IMPROVED PURIFICATION OF 4, 4'(5')-DI-t-BUTYLCYCLOHEXANO-18-CROWN-6
05/21/2003	EP1005369B1 Use of a texaphyrin in the preparation of a medicament for use in ocular diagnosis and therapy
05/01/2003	WO2001096318A8 Cyclic urea compounds and preparation thereof
03/2003
03/27/2003	WO2003024940A1 Bifunctional chelating agent for actinium
03/12/2003	EP1289968A1 Cyclic urea compounds and preparation thereof
02/2003
02/26/2003	EP0832068B1 Stable reagents for the preparation of radiopharmaceuticals
02/25/2003	US6525041 Low molecular weight mimics of superoxide dismutase; inflammatory disorders, ischemic/reperfusion injury, stroke, atherosclerosis, and all other conditions of oxidant- induced tissue damage or injury
02/06/2003	US20030027302 Ligand for use in radioimmunotherapy
12/2002
12/11/2002	EP1263741A1 Bifunctional chelating agent
10/2002
10/22/2002	US6468406 Anion-complexing compound, method of preparing the same, an ion-selective membrane and a sensor provided with such a compound or membrane
10/10/2002	WO2002055111A3 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
10/03/2002	US20020143191 Novel stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas
09/2002
09/18/2002	CN1370161A Novel quaternary ammonium compounds, its prepn. methods and medicinal application
09/12/2002	US20020128470 Purification process
09/04/2002	EP0748229B1 Polychelants
07/2002
07/18/2002	WO2002055111A2 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
07/18/2002	CA2429956A1 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
07/17/2002	EP1223166A1 Linked cyclic polyamines with activity against hiv.
07/11/2002	WO2002040507A3 Novel compounds for uses in radioimmunoscintigraphy and/or radioimmunotherapy of cancers
05/2002
05/23/2002	WO2002040507A2 Novel compounds for uses in radioimmunoscintigraphy and/or radioimmunotherapy of cancers
04/2002
04/23/2002	CA2032261C Antiviral polyheterocyclic dimers
03/2002
03/13/2002	EP1185526A1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use
01/2002
01/22/2002	US6340745 Phthalocyanine and use of phthalocyanine as a marking agent
12/2001
12/20/2001	WO2001096318A1 Cyclic urea compounds and preparation thereof
12/20/2001	CA2778314A1 Cyclic urea compounds and preparation thereof
10/2001
10/30/2001	US6310202 Nitric oxide carriers based on polyazamacrocycle complexes
10/25/2001	WO2000040605A9 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
10/17/2001	EP1144414A2 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
10/10/2001	EP1140822A1 Stable activated novel carbamic acid derivatives, preparation method and use for preparing urea
09/2001
09/20/2001	WO2001068618A1 Bifunctional chelating agent
09/11/2001	US6288224 Preparation of n-arylmethyl aziridine derivatives, 1,4,7,10-tetraazacyclododecane derivatives obtained therefrom and n-arylethyl-ethanolamine sulphonate esters as intermediates
08/2001
08/01/2001	CN1305992A Method for preparing aryl alkyl hydrogen peroxide
08/01/2001	CN1305991A Method for preparing aryl alkyl hydrogen peroxide
03/2001
03/20/2001	US6204259 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
02/2001
02/07/2001	EP1073629A1 Anion-complexing compound, method of preparing the same, an ion-selective membrane and a sensor provided with such a compound or membrane
01/2001
01/04/2001	WO2001000621A1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use
01/04/2001	CA2377154A1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use
11/2000
11/30/2000	WO2000040605A3 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
10/2000
10/12/2000	WO2000059896A1 225Ac-HEHA AND RELATED COMPOUNDS, METHODS OF SYNTHESIS AND METHODS OF USE
08/2000
08/30/2000	CN1265039A Use of texaphyrin in prepn. of medicament for use in ocular diagnosis and therapy
07/2000
07/20/2000	WO2000042009A1 Stable activated novel carbamic acid derivatives, preparation method and use for preparing urea
07/13/2000	WO2000040605A2 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
07/13/2000	CA2358119A1 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
07/05/2000	EP0692982B1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS
07/04/2000	US6084093 Substituted 1,4,7,10,13-pentaazacyclopentadecane macrocyclic ligands; manganese complexes of the ligand are mimics of superoxide dismutase; useful as therapeutic agents for inflammatory diseases
06/2000
06/07/2000	EP1005369A2 Use of a texaphyrin in the preparation of a medicament for use in ocular diagnosis and therapy
06/07/2000	CN1255922A Phthalocyanine and use of phthalocyanine as marking agent
04/2000
04/26/2000	EP0995761A2 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
04/11/2000	US6048979 Cyclotetramerizing, cleavage of arylmethyl groups to prepare cyclen and derivatives
03/2000
03/29/2000	CN1050836C Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates preparation process
03/28/2000	CA2160270C 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same
03/08/2000	EP0983283A1 Nitric oxide carriers based on polyazamacrocycle complexes
03/08/2000	EP0983274A1 Phthalocyanine and use of phthalocyanine as a marking agent
02/2000
02/22/2000	US6028193 Catalyzing the oxidation reaction in presence of a transition metal complex which contains a cyclic polyfunctional amine compound having at least three nitrogen atoms in the ring forming molecular
02/08/2000	US6022523 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
01/2000
01/18/2000	US6015904 Stable reagents for the preparation of radio pharmaceuticals
12/1999
12/09/1999	WO1998025648A3 Use of a texaphyrin in ocular diagnosis and therapy
11/1999
11/02/1999	US5976498 Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands
11/02/1999	US5976493 Metabolically cleavable dendrimeric polychelants
10/1999
10/19/1999	US5969081 Cyclic oligomers comprising m-phenylene isophthalamide and polymers thereof
10/14/1999	WO1999051570A1 Anion-complexing compound, method of preparing the same, an ion-selective membrane and a sensor provided with such a compound or membrane
10/14/1999	CA2326844A1 Anion-complexing compound, method of preparing the same, an ion-selective membrane and a sensor provided with such a compound or membrane
08/1999
08/31/1999	US5945572 Method for producing aryl alkyl hydroperoxides
08/11/1999	CN1225631A Bioconjugates of manganese or iron complexes of nitrogen-contg. macrocyclic ligands effective as catalysis for dismutating superoxide
03/1999
03/09/1999	US5879657 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
02/1999
02/23/1999	US5874421 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
02/16/1999	US5872117 Treating cerebrovascular dementia, senile dementia, alzheimer's dementia, sequelae of ischemic encephalopathy and cerebral apoplexy
02/09/1999	US5869651 Hydrazide derivatives of polyamides and their medical use as chelating agents
01/1999
01/20/1999	EP0891338A1 Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
01/07/1999	EP0888115A1 Iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
12/1998
12/08/1998	US5847227 Method for producing aryl alkyl hydroperoxides
12/02/1998	EP0691986B1 NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS
11/1998
11/26/1998	WO1998052950A1 Phthalocyanine and use of phthalocyanine as a marking agent
11/26/1998	DE19721399A1 Phthalocyanine und ihre Verwendung als Markierungsmittel Phthalocyanines and their use as markers
11/25/1998	CN1200039A Bioconjugates of manganese complexes containing nitrogen macrocyclic ligand, and their application as catalysts of disproportionated super-oxide
11/18/1998	CN1040750C Polyazamacrocyclic compounds for complexation of metal ions
11/12/1998	WO1998050394A1 Nitric oxide carriers based on polyazamacrocycle complexes
11/12/1998	CA2287981A1 Nitric oxide carriers based on polyazamacrocycle complexes
10/1998
10/06/1998	US5817807 Containing a 1,4,8,11-tetraazacyclotetradecane ring
10/06/1998	US5817749 Cyclic pentapeptides
09/1998
09/15/1998	US5808003 Polyaminocarboxylate chelators
09/09/1998	CN1192733A Stable reagent for prepn. of radiopharmaceuticals
09/02/1998	CN1192160A Chelating polymers as contrast agents for medical imaging
09/01/1998	US5801228 Polymeric contrast agents for medical imaging
08/1998
08/26/1998	CN1191530A Manganese or iron complexes of nitrogen-contg. macrocyclic ligands effective as catalysts for dismutating superoxide
08/25/1998	US5798089 Chelant moieties linked to an aryl moiety by an interrupted alkylene linker

1 2 3 4 5